BroadOak Capital Partners is a privately-held investment bank with a comprehensive focus on the life sciences industry. The firm offers advisory services including mergers and acquisitions, divestitures, capital formation, valuations and fairness opinions. Their sector focus includes research tools and consumables, diagnostics, therapeutics, healthcare IT, pharmaceutical services and medical devices. BroadOak was established in 2006 and is headquartered in Bethesda, Maryland
BroadOak Capital Partners' investments include Horizon Infusions, Particle Dynamics, Argonaut Manufacturing Services, Honeycomb Biotechnologies, rareLife Solutions, Azure Biosystems, SGI-DNA, seqWell and Reaction Biology Corporation.
D. Kyle Wilson